ARTICLE | Company News
Biofrontera acquires dermatology compound
September 13, 2005 12:31 AM UTC
Biofrontera (Leverkusen, Germany) acquired from Switch (Neuried, Germany) an undisclosed compound to treat dermatological indications. Biofrontera, which will develop the compound for atopic dermatiti...